Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WEIZMAN A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 247 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jeczmien, P; Levkovitz, Y; Weizman, A; Carmel, Z
      Post-psychotic depression in schizophrenia

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    2. Strous, RD; Spivak, B; Yoran-Hegesh, R; Maayan, R; Averbuch, E; Kotler, M; Mester, R; Weizman, A
      Analysis of neurosteroid levels in attention deficit hyperactivity disorder

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    3. Gurwitz, D; Weizman, A
      Animal models and human genome diversity: the pitfalls of inbred mice

      DRUG DISCOVERY TODAY
    4. Frisch, A; Laufer, N; Danziger, Y; Michaelovsky, E; Leor, S; Carel, C; Stein, D; Fenig, S; Mimouni, M; Apter, A; Weizman, A
      Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients

      MOLECULAR PSYCHIATRY
    5. Nahshoni, E; Aizenberg, D; Sigler, M; Zalsman, G; Strasberg, B; Imbar, S; Weizman, A
      Heart rate variability in elderly patients before and after electroconvulsive therapy

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    6. Spivak, B; Mozes, T; Mester, R; Kodelik, M; Weizman, A
      Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: An open-label study

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    7. Shiloh, R; Weizman, A; Epstein, Y; Rosenberg, SL; Valevski, A; Dorfman-Etrog, P; Wiezer, N; Katz, N; Munitz, H; Hermesh, H
      Abnormal thermoregulation in drug-free male schizophrenia patients

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Zemishlany, Z; Aizenberg, D; Weizman, A
      Subjective effects of MDMA ('ecstasy') on human sexual function

      EUROPEAN PSYCHIATRY
    9. Reznik, I; Mester, R; Kotler, M; Weizman, A
      Obsessive-compulsive schizophrenia: A new diagnostic entity?

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    10. Avital, A; Richter-Levin, G; Leschiner, S; Spanier, I; Veenman, L; Weizman, A; Gavish, M
      Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney

      NEUROPSYCHOPHARMACOLOGY
    11. Vered, Y; Spivak, B; Nechmad, A; Schlapnikov, N; Graff, E; Feinberg, I; Gruper, D; Weiss, M; Kotler, M; Weizman, A; Mester, R
      Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    12. Spivak, B; Vered, Y; Yoran-Hegesh, R; Graff, E; Averbuch, E; Vinokurow, S; Weizman, A; Mester, R
      The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    13. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
      Response of catatonia to risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    14. Davidson, S; Shtaif, B; Gil-Ad, I; Maayan, R; Sulkes, J; Weizman, A; Merlob, P
      Insulin, insulin-like growth factors-I and -II and insulin-like growth factor binding protein-3 in newborn serum: Association with normal fetal head growth and head circumference

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    15. Naisberg, Y; Modai, I; Weizman, A
      Metabolic bioenergy homeostatic disruption: a cause of anorexia nervosa

      MEDICAL HYPOTHESES
    16. Zucker, M; Weizman, A; Harel, D; Rehavi, M
      Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs

      NEUROPSYCHOBIOLOGY
    17. Kohn, Y; Weizman, A; Apter, A
      Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine amd fluoxetine

      INTERNATIONAL JOURNAL OF EATING DISORDERS
    18. Fischel, T; Hermesh, H; Aizenberg, D; Zemishlany, Z; Munitz, H; Benjamini, Y; Weizman, A
      Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    19. Hadas-Lidor, N; Katz, N; Tyano, S; Weizman, A
      Effectiveness of dynamic cognitively intervention in rehabilitation of clients with schizophrenia

      CLINICAL REHABILITATION
    20. Poyurovsky, M; Hramenkov, S; Isakov, V; Rauchverger, B; Modai, I; Schneidman, M; Fuchs, C; Weizman, A
      Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia

      PSYCHIATRY RESEARCH
    21. Stein, D; Ring, A; Shulman, C; Meir, D; Holan, A; Weizman, A; Barak, Y
      Brief report: Children with autism as they grow up - Description of adult inpatients with severe autism

      JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
    22. Aizenberg, D; Modai, I; Landa, A; Gil-Ad, I; Weizman, A
      Comparison of sexual dysfunction in male schizophrenic patients maintainedon treatment with classical antipsychotics versus clozapine

      JOURNAL OF CLINICAL PSYCHIATRY
    23. Zalsman, G; Frisch, A; King, RA; Pauls, DL; Grice, DE; Gelernter, J; Alsobrook, J; Michaelovsky, E; Apter, A; Tyano, S; Weizman, A; Leckman, JF
      Case control and family-based studies of tryptophan hydroxylase gene A218Cpolymorphism and suicidality in adolescents

      AMERICAN JOURNAL OF MEDICAL GENETICS
    24. Zalsman, G; Frisch, A; Bromberg, M; Gelernter, J; Michaelovsky, E; Campino, A; Erlich, Z; Tyano, S; Apter, A; Weizman, A
      Family-based association study of serotonin transporter promoter in suicidal adolescents: No association with suicidality but possible role in violence traits

      AMERICAN JOURNAL OF MEDICAL GENETICS
    25. Gurwitz, D; Weizman, A
      Fatty acid amide hydrolase inhibitors and the marijuana debate

      LANCET
    26. Valevski, A; Ratzoni, G; Sever, J; Apter, A; Zalsman, G; Shiloh, R; Weizman, A; Tyano, S
      Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients

      JOURNAL OF ADOLESCENCE
    27. Finzi, R; Ram, A; Har-Even, D; Shnit, D; Weizman, A
      Attachment styles and aggression in physically abused and neglected children

      JOURNAL OF YOUTH AND ADOLESCENCE
    28. Zucker, M; Weizman, A; Rehavi, M
      Characterization of high-affinity [H-3]TBZOH binding to the human plateletvesicular monoamine transporter

      LIFE SCIENCES
    29. Golan, M; Weizman, A
      Familial approach to the treatment of childhood obesity: Conceptual model

      JOURNAL OF NUTRITION EDUCATION
    30. Zalsman, G; Weizman, A; Carel, CA; Aizenberg, D
      Geriatric Depression Scale (GDS-15): A sensitive and convenient instrumentfor measuring depression in young anorexic patients

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    31. Weizman, A; Stevenson, DJ; Prialnik, D; Podolak, M
      Modeling the volcanism on Mars

      ICARUS
    32. Poyurovsky, M; Weizman, A
      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: anew approach to an old problem

      BRITISH JOURNAL OF PSYCHIATRY
    33. Golani, I; Weizman, A; Leschiner, S; Spanier, I; Eckstein, N; Limor, R; Yanai, J; Maaser, K; Scherubl, H; Weisinger, G; Gavish, M
      Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction

      BIOCHEMISTRY
    34. Poyurovsky, M; Weizman, A
      Mirtazapine for neuroleptic-induced akathisia

      AMERICAN JOURNAL OF PSYCHIATRY
    35. Shiloh, R; Weizman, A; Weizer, N; Dorfman-Etrog, P; Munitz, H
      Risperidone-induced retrograde ejaculation

      AMERICAN JOURNAL OF PSYCHIATRY
    36. Finzi, R; Ram, A; Shnit, D; Har-Even, D; Tyano, S; Weizman, A
      Depressive symptoms and suicidality in physically abused children

      AMERICAN JOURNAL OF ORTHOPSYCHIATRY
    37. Nofech-Mozes, Y; Yuhas, Y; Kaminsky, E; Weizman, A; Ashkenazi, S
      Induction of mRNA for tumor necrosis factor-alpha and interleukin-1 beta in mice brain, spleen and liver in an animal model of Shigella-related seizures

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    38. Swartz, M; Barak, Y; Mirecki, I; Naor, S; Weizman, A
      Treating depression in Alzheimer's disease: Integration of differing guidelines

      INTERNATIONAL PSYCHOGERIATRICS
    39. Persson, ML; Wasserman, D; Geijer, T; Frisch, A; Rockah, R; Michaelovsky, E; Apter, A; Weizman, A; Jonsson, EG; Bergman, H
      Dopamine D4 receptor gene polymorphism and personality traits in healthy volunteers

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    40. Shiloh, R; Hermesh, H; Weizer, N; Dorfman-Etrog, P; Weizman, A; Munitz, H
      Acute antipsychotic drug administration lowers body temperature in drug-free male schizophrenic patients

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    41. Gothelf, D; Soreni, N; Nachman, RP; Tyano, S; Hiss, Y; Reiner, O; Weizman, A
      Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    42. Gross-Isseroff, R; Weizman, A; Fieldust, SJ; Israeli, M; Biegon, A
      Unaltered alpha(2)-noradrenergic/imidazoline receptors in suicide victims:a postmortem brain autoradiographic analysis

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    43. Rehavi, M; Attali, G; Gil-Ad, I; Weizman, A
      Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    44. Poyurovsky, M; Nave, R; Epstein, R; Tzischinsky, O; Schneidman, M; Barnes, TRE; Weizman, A; Lavie, P
      Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    45. Spivak, B; Elimelech, D; Ocring, R; Mester, R; Kotler, M; Weizman, A
      Hemispheric function in disorganized type schizophrenia: performance on the Quality Extinction Test

      EUROPEAN PSYCHIATRY
    46. Grinshpoon, A; Valevski, A; Moskowitz, M; Weizman, A
      Beneficial effect of the addition of the 5-HT 2A/2C and alpha 2 antagonistmianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients

      EUROPEAN PSYCHIATRY
    47. Spivak, B; Maline, DI; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Weizman, A
      Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow

      EUROPEAN PSYCHIATRY
    48. Zalsman, G; Netanel, R; Fischel, T; Freudenstein, O; Landau, E; Orbach, I; Weizman, A; Pfeffer, CR; Apter, A
      Human figure drawings in the evaluation of severe adolescent suicidal behavior

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    49. Salman, H; Bergman, M; Weizman, A; Bessler, H; Weiss, J; Straussberg, R; Djaldetti, M
      Effect of diazepam on the immune response of rats exposed to acute and chronic swim stress

      BIOMEDICINE & PHARMACOTHERAPY
    50. Reznik, I; Volchek, L; Mester, R; Kotler, M; Sarova-Pinhas, I; Spivak, B; Weizman, A
      Myotoxicity and neurotoxicity during clozapine treatment

      CLINICAL NEUROPHARMACOLOGY
    51. Kupchik, M; Spivak, B; Mester, R; Reznik, I; Gonen, N; Weizman, A; Kotler, M
      Combined electroconvulsive-clozapine therapy

      CLINICAL NEUROPHARMACOLOGY
    52. Valevski, A; Fridberg, G; Gil-Ad, I; Laron, Z; Weizman, A
      Neuroendocrinological response to standardized mixed meal in female anorectic patients during active and refeeding phases

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    53. Naisberg, Y; Modai, I; Weizman, A
      Homeostatic biophasal conscious regulation

      MEDICAL HYPOTHESES
    54. Naisberg, Y; Modai, I; Weizman, A
      The wired network as a learning paradigm for normal and abnormal brain neuronal communication

      MEDICAL HYPOTHESES
    55. Naisberg, Y; Modai, I; Weizman, A
      Abnormal neuronal ionic flux activity: learning paradigms of schizophrenicthought disorders

      MEDICAL HYPOTHESES
    56. Galili-Mosberg, R; Gil-Ad, I; Weizman, A; Melamed, E; Offen, D
      Haloperidol - induced neurotoxicity - possible implications for tardive dyskinesia

      JOURNAL OF NEURAL TRANSMISSION
    57. Poyurovsky, M; Dorfman-Etrog, P; Hermesh, H; Munitz, H; Tollefson, GD; Weizman, A
      Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    58. Lerner, AG; Gelkopf, M; Oyffe, I; Finkel, B; Katz, S; Sigal, M; Weizman, A
      LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    59. Munitz, H; Valevski, A; Weizman, A; Prilipko, L; Baudis, P; Skoda, C; Boussaid, F; Moussaoui, D; Belyanchikova, MA; Bobrov, AE; Tsirkin, S; Gan, YF; Channabasavanna, SM
      Recognition and treatment of depression in primary care settings in 6 different countries: A retrospective file analysis by WHO

      EUROPEAN JOURNAL OF PSYCHIATRY
    60. Nahshoni, E; Aizenberg, D; Strasberg, B; Dorfman, P; Sigler, M; Imbar, S; Weizman, A
      QT dispersion in the surface electrocardiogram in elderly patients with major depression

      JOURNAL OF AFFECTIVE DISORDERS
    61. Spivak, B; Segal, M; Laufer, N; Mester, R; Weizman, A
      Lifetime psychiatric comorbidity rate in Israeli non-help-seeking patientswith combat-related post-traumatic stress disorder

      JOURNAL OF AFFECTIVE DISORDERS
    62. Spivak, B; Maayan, R; Kotler, M; Mester, R; Gil-Ad, I; Shtaif, B; Weizman, A
      Elevated circulatory level of GABA(A) - antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder

      PSYCHOLOGICAL MEDICINE
    63. Zalsman, G; Aizenberg, D; Sigler, M; Nahshony, E; Karp, L; Weizman, A
      Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression

      JOURNAL OF NERVOUS AND MENTAL DISEASE
    64. Finzi, R; Cohen, O; Sapir, Y; Weizman, A
      Attachment styles in maltreated children: A comparative study

      CHILD PSYCHIATRY & HUMAN DEVELOPMENT
    65. Maayan, R; Yagorowski, Y; Grupper, D; Weiss, M; Shtaif, B; Abou Kaoud, M; Weizman, A
      Basal plasma dehydroepiandrosterone sulfate level: A possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients

      BIOLOGICAL PSYCHIATRY
    66. Hermesh, H; Shiloh, R; Epstein, Y; Manaim, H; Weizman, A; Munitz, H
      Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs

      AMERICAN JOURNAL OF PSYCHIATRY
    67. Spivak, B; Maline, DI; Vered, Y; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Graff, E; Weizman, A
      Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome

      ACTA PSYCHIATRICA SCANDINAVICA
    68. Gil-Ad, I; Shtaif, B; Luria, D; Karp, L; Fridman, Y; Weizman, A
      Insulin-like-growth-factor-I (IGF-I) antagonises apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture

      GROWTH HORMONE & IGF RESEARCH
    69. Leykin, I; Spivak, B; Weizman, A; Cohen, IR; Shinitzky, M
      Elevated cellular immune response to human heat-shock protein-60 in schizophrenic patients

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    70. Dorfman-Etrog, P; Hermesh, H; Prilipko, L; Weizman, A; Munitz, H
      The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    71. Zohar, J; Hermesh, H; Weizman, A; Voet, H; Gross-Isseroff, R
      Obitofrontal cortex dysfunction in obsessive-compulsive disorder? I. Alternation learning in obsessive-compulsive disorder: male-female comparisons

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    72. Hermesh, H; Zohar, J; Weizman, A; Voet, H; Gross-Isseroff, R
      Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? II. Olfactory quality discrimination in obsessive-compulsive disorder

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    73. Valevski, A; Averbuch, I; Radwan, M; Gur, S; Spivak, B; Modai, I; Weizman, A
      Homicide by schizophrenic patients in Israel

      EUROPEAN PSYCHIATRY
    74. Gothelf, D; Frisch, A; Munitz, H; Rockah, R; Laufer, N; Mozes, T; Hermesh, H; Weizman, A; Frydman, M
      Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome

      SCHIZOPHRENIA RESEARCH
    75. Weizman, A; Dagan, E; Kaplan, B; Karp, L; Malmud, S; Gil-Ad, I; Leschiner, S; Snyder, SH; Gavish, M
      Platelet peripheral-type benzodiazepine in pregnancy and lactation

      NEUROPSYCHOPHARMACOLOGY
    76. Aizenberg, D; Naor, S; Zemishlany, Z; Weizman, A
      The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: An open-label add-on study

      CLINICAL NEUROPHARMACOLOGY
    77. Spivak, B; Lamschtein, C; Talmon, Y; Guy, N; Mester, R; Feinberg, I; Kotler, M; Weizman, A
      The impact of clozapine treatment on serum lipids in chronic schizophrenicpatients

      CLINICAL NEUROPHARMACOLOGY
    78. Laufer, N; Spivak, B; Holdengreber, V; Zipser, J; Kosower, N; Ragolsky, M; Weizman, A
      H-3-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment

      CLINICAL NEUROPHARMACOLOGY
    79. Naisberg, Y; Weizman, A
      Biophysical shunt theory for neuropsychopathology: biphasal homeostatic dysregulation

      MEDICAL HYPOTHESES
    80. Naisberg, Y; Weizman, A
      Biophysical shunt theory for neuropsychopathology: pentaphasic lipid-induced model for schizophrenia

      MEDICAL HYPOTHESES
    81. Naisberg, Y; Weizman, A
      Biophysical shunt theory for neuropsychopathology: neuroimmunological causality for the suicide condition

      MEDICAL HYPOTHESES
    82. Poyurovsky, M; Weizman, A
      Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    83. Toren, P; Laor, N; Cohen, DJ; Wolmer, L; Weizman, A
      Ondansetron treatment in patients with Tourette's syndrome

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    84. Spivak, B; Musin, E; Mester, R; Gonen, N; Talmon, Y; Guy, N; Roitman, S; Kupchik, M; Kotler, M; Weizman, A
      The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    85. Poyurovsky, M; Isakov, V; Hromnikov, S; Modai, I; Rauchberger, B; Schneidman, M; Weizman, A
      Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    86. Zohar, J; Gross-Isseroff, R; Hermesh, H; Weizman, A
      Is there sexual dimorphism in obsessive-compulsive disorder?

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    87. Golan, M; Weizman, A; Fainaru, M
      Impact of treatment for childhood obesity on parental risk factors for cardiovascular disease

      PREVENTIVE MEDICINE
    88. Volovitz, B; Tabachnik, E; Nussinovitch, M; Shtaif, B; Blau, H; Gil-Ad, I; Weizman, A; Varsano, I
      Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    89. Gavish, M; Bachman, I; Shoukrun, R; Katz, Y; Veenman, L; Weisinger, G; Weizman, A
      Enigma of the peripheral benzodiazepine receptor

      PHARMACOLOGICAL REVIEWS
    90. Sher, I; Weizman, A; Lubinsky-Mink, S; Lang, T; Adir, N; Schomburg, D; Ron, D
      Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs

      JOURNAL OF BIOLOGICAL CHEMISTRY
    91. Yuhas, Y; Shulman, L; Weizman, A; Kaminsky, E; Vanichkin, A; Ashkenazi, S
      Involvement of tumor necrosis factor alpha and interleukin-1 beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae

      INFECTION AND IMMUNITY
    92. Balter-Seri, J; Yuhas, Y; Weizman, A; Nofech-Mozes, Y; Kaminsky, E; Ashkenazi, S
      Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae

      INFECTION AND IMMUNITY
    93. Barak, Y; Wittenberg, N; Naor, S; Kutzuk, D; Weizman, A
      Clozapine in elderly psychiatric patients: Tolerability, safety, and efficacy

      COMPREHENSIVE PSYCHIATRY
    94. Barak, Y; Kimhi, R; Stein, D; Gutman, J; Weizman, A
      Autistic subjects with comorbid epilepsy: A possible association with viral infections

      CHILD PSYCHIATRY & HUMAN DEVELOPMENT
    95. Poyurovsky, M; Shardorodsky, M; Fuchs, C; Schneidman, M; Weizman, A
      Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin - Double-blind, placebo-controlled study

      BRITISH JOURNAL OF PSYCHIATRY
    96. Soreni, N; Apter, A; Weizman, A; Don-Tufeled, O; Leschiner, S; Karp, L; Gavish, M
      Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts

      BIOLOGICAL PSYCHIATRY
    97. Apter, A; Laufer, N; Bar-Sever, M; Har-Even, D; Ofek, H; Weizman, A
      Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients

      BIOLOGICAL PSYCHIATRY
    98. Spivak, B; Vered, Y; Graff, E; Blum, I; Mester, R; Weizman, A
      Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder

      BIOLOGICAL PSYCHIATRY
    99. Nordenberg, J; Fenig, E; Landau, M; Weizman, R; Weizman, A
      Effects of psychotropic drugs on cell proliferation and differentiation

      BIOCHEMICAL PHARMACOLOGY
    100. Poyurovsky, M; Fuchs, C; Weizman, A
      Obsessive-compulsive disorder in patients with first-episode schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:53:08